Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9444249Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2024
Linked Award Amount
$1.7M
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#6,863
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Tage Honore as a PI. Multi-PI records show the full award amount for context.
- 1U01AG088113-01U01Development of EP2 Receptor Antagonist to Treat Alzheimer's Disease$1.7Maward amount
Award organization
Organizations that administered FY2024 awards listing Tage Honore as a PI.
FY2024 award administered by Emory University (GA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardEmory University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6863
- 2025$2M Cumulative Funding
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #3613
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Tage Honore.